首页 > 最新文献

Biochemistry Research International最新文献

英文 中文
Ozoroa insignis reticulata (Baker f.) R. Fern. & A. Fern. Root Extract Inhibits the Production of Extracellular Proteases by Staphylococcus aureus. Ozoroa insignis reticulata (Baker f.) R. Fern. & A.Fern.根提取物可抑制金黄色葡萄球菌产生胞外蛋白酶。
IF 3.4 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-10-29 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5599129
Jonathan Katsukunya, Rumbidzai Makurira, Stanley Mukanganyama

Treatment of infections caused by S. aureus has become a challenge due to the emergency of resistant strains. Ozoroa reticulata root extracts have been used in traditional medicine to treat throat and chest pains in Zimbabwe. The objective of the study was to determine the effects of O. reticulata root bark extracts on the production of extracellular proteases by S. aureus. The root barks were collected, dried, and crushed into powder. To obtain different phytoconstituents, plant extractions were performed. Extractions were carried out using two solvent mixtures: ethanol : water (50 : 50 v/v) and dichloromethane : methanol (50 : 50 v/v). Serial exhaustive extractions were also performed using methanol, ethanol, dichloromethane, acetone, ethyl acetate, hexane, and water. The broth microdilution assays were used to assess the antibacterial effects of the Ozoroa reticulata root bark extracts against S. aureus. Ciprofloxacin was used as a positive control. Qualitative screening for extracellular protease production by S. aureus on BCG-skim milk agar plates using the most potent extract was carried out. The proteolytic zones were measured and expressed as the ratio of the diameter of the colony to the total diameter of the colony plus the zone of hydrolysis (P z values). The ethyl acetate extract was found to be the most potent inhibitor of the growth of S. aureus with 99% inhibition and a minimum inhibitory concentration (MIC) of 100 µg/mL. Inhibition of extracellular protease production was directly proportional to the concentration of the extract. At 100 µg/mL, the ethyl acetate extract had a P z value of 0.84, indicative of mild proteolytic activity. A P z value of 0.94 was observed at a concentration of 200 µg/mL and signified weak proteolytic activity. In conclusion, the extract inhibited the production of extracellular proteases in S. aureus. Further work on the isolation and purification of bioactive compounds responsible for inhibiting the production of extracellular proteases is of importance in the discovery of agents with antivirulent effects on S. aureus.

由于耐药菌株的紧急出现,治疗由金黄色葡萄球菌引起的感染已成为一项挑战。在津巴布韦,Ozoroa reticulata 根提取物一直被用于治疗喉咙和胸痛的传统医学中。本研究的目的是确定 O. reticulata 根皮提取物对金黄色葡萄球菌产生胞外蛋白酶的影响。采集根皮,将其干燥并碾成粉末。为了获得不同的植物成分,进行了植物萃取。萃取使用两种混合溶剂:乙醇:水(50:50 v/v)和二氯甲烷:甲醇(50:50 v/v)。此外,还使用甲醇、乙醇、二氯甲烷、丙酮、乙酸乙酯、正己烷和水进行了连续穷举提取。肉汤微量稀释法用于评估 Ozoroa 网纹根树皮提取物对金黄色葡萄球菌的抗菌效果。环丙沙星用作阳性对照。在卡介苗-金黄色葡萄球菌琼脂平板上,使用最有效的提取物对金黄色葡萄球菌产生的胞外蛋白酶进行定性筛选。对蛋白水解区进行了测量,并以菌落直径与菌落直径加水解区总直径之比(P z 值)表示。研究发现,乙酸乙酯提取物是金黄色葡萄球菌生长的最有效抑制剂,抑制率达 99%,最低抑制浓度 (MIC) 为 100 µg/mL。对细胞外蛋白酶生成的抑制作用与提取物的浓度成正比。当浓度为 100 µg/mL 时,乙酸乙酯提取物的 P z 值为 0.84,表明其具有轻微的蛋白水解活性。浓度为 200 µg/mL 时,P z 值为 0.94,表明蛋白水解活性较弱。总之,该提取物抑制了金黄色葡萄球菌胞外蛋白酶的产生。进一步分离和纯化能抑制细胞外蛋白酶产生的生物活性化合物,对于发现对金黄色葡萄球菌具有抗病毒作用的制剂具有重要意义。
{"title":"<i>Ozoroa insignis reticulata</i> (Baker f.) R. Fern. & A. Fern. Root Extract Inhibits the Production of Extracellular Proteases by <i>Staphylococcus aureus</i>.","authors":"Jonathan Katsukunya, Rumbidzai Makurira, Stanley Mukanganyama","doi":"10.1155/2021/5599129","DOIUrl":"10.1155/2021/5599129","url":null,"abstract":"<p><p>Treatment of infections caused by <i>S. aureus</i> has become a challenge due to the emergency of resistant strains. <i>Ozoroa reticulata</i> root extracts have been used in traditional medicine to treat throat and chest pains in Zimbabwe. The objective of the study was to determine the effects of <i>O. reticulata</i> root bark extracts on the production of extracellular proteases by <i>S. aureus</i>. The root barks were collected, dried, and crushed into powder. To obtain different phytoconstituents, plant extractions were performed. Extractions were carried out using two solvent mixtures: ethanol : water (50 : 50 v/v) and dichloromethane : methanol (50 : 50 v/v). Serial exhaustive extractions were also performed using methanol, ethanol, dichloromethane, acetone, ethyl acetate, hexane, and water. The broth microdilution assays were used to assess the antibacterial effects of the <i>Ozoroa reticulata</i> root bark extracts against <i>S. aureus</i>. Ciprofloxacin was used as a positive control. Qualitative screening for extracellular protease production by <i>S. aureus</i> on BCG-skim milk agar plates using the most potent extract was carried out. The proteolytic zones were measured and expressed as the ratio of the diameter of the colony to the total diameter of the colony plus the zone of hydrolysis (<i>P</i> <sub><i>z</i></sub> values). The ethyl acetate extract was found to be the most potent inhibitor of the growth of <i>S. aureus</i> with 99% inhibition and a minimum inhibitory concentration (MIC) of 100 <i>µ</i>g/mL. Inhibition of extracellular protease production was directly proportional to the concentration of the extract. At 100 <i>µ</i>g/mL, the ethyl acetate extract had a <i>P</i> <sub><i>z</i></sub> value of 0.84, indicative of mild proteolytic activity. A <i>P</i> <sub><i>z</i></sub> value of 0.94 was observed at a concentration of 200 <i>µ</i>g/mL and signified weak proteolytic activity. In conclusion, the extract inhibited the production of extracellular proteases in <i>S. aureus</i>. Further work on the isolation and purification of bioactive compounds responsible for inhibiting the production of extracellular proteases is of importance in the discovery of agents with antivirulent effects on <i>S. aureus</i>.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"5599129"},"PeriodicalIF":3.4,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39597982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Biochemical Analysis of Patients with COVID-19 Infection. COVID-19 感染患者的生化分析
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-10-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/1383830
Adil R Sarhan, Thaer A Hussein, Mohammed H Flaih, Khwam R Hussein

Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established. Here, we report clinical and blood biochemical indicators of 100 patients with COVID-19. Throat-swab upper respiratory samples were obtained from patients and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, and clinical features such as diabetes mellitus, hypertension, and smoking habits were investigated. Biochemical parameters were categorized and analyzed according to these clinical characteristics. Triglycerides, GPT, and ALP are the biochemical markers that changed the most in the group of hypertension patients. Cholesterol and triglycerides were significantly different (P=0.01; P=0.04, respectively) between diabetic and nondiabetic patients with COVID-19. Potassium levels were significantly different (P=0.03) when comparing smokers with nonsmoker patients. Our results suggest several potential biochemical indexes that changed in patients with COVID-19 and whether certain comorbidity and clinical characteristics influence these markers.

多项研究表明,年龄、合并症和不同临床生物标志物的异常对于了解疾病的严重程度非常重要。尽管 COVID-19 的临床特征已被广泛描述,但对 COVID-19 患者最常见的生化指标变化的评估仍未得到很好的证实。在此,我们报告了 100 例 COVID-19 患者的临床和血液生化指标。我们采集了患者的喉拭子上呼吸道样本,并采用实时 PCR 技术确认 SARS-CoV-2 感染。对性别、年龄以及糖尿病、高血压和吸烟习惯等临床特征进行了调查。根据这些临床特征对生化指标进行了分类和分析。在高血压患者组中,甘油三酯、GPT 和 ALP 是变化最大的生化指标。患有 COVID-19 的糖尿病和非糖尿病患者的胆固醇和甘油三酯有显著差异(分别为 P=0.01 和 P=0.04)。吸烟者与非吸烟者相比,钾水平有明显差异(P=0.03)。我们的研究结果表明,COVID-19 患者的几种潜在生化指标会发生变化,某些合并症和临床特征是否会影响这些指标。
{"title":"A Biochemical Analysis of Patients with COVID-19 Infection.","authors":"Adil R Sarhan, Thaer A Hussein, Mohammed H Flaih, Khwam R Hussein","doi":"10.1155/2021/1383830","DOIUrl":"10.1155/2021/1383830","url":null,"abstract":"<p><p>Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established. Here, we report clinical and blood biochemical indicators of 100 patients with COVID-19. Throat-swab upper respiratory samples were obtained from patients and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, and clinical features such as diabetes mellitus, hypertension, and smoking habits were investigated. Biochemical parameters were categorized and analyzed according to these clinical characteristics. Triglycerides, GPT, and ALP are the biochemical markers that changed the most in the group of hypertension patients. Cholesterol and triglycerides were significantly different (<i>P</i>=0.01; <i>P</i>=0.04, respectively) between diabetic and nondiabetic patients with COVID-19. Potassium levels were significantly different (<i>P</i>=0.03) when comparing smokers with nonsmoker patients. Our results suggest several potential biochemical indexes that changed in patients with COVID-19 and whether certain comorbidity and clinical characteristics influence these markers.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"1383830"},"PeriodicalIF":3.0,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39562512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Spectroscopic (FTIR and UV-Vis) and Hyphenated Chromatographic (UHPLC-qTOF-MS) Analysis and In Vitro Bioactivities of the Momordica balsamina Leaf Extract. 分子光谱(FTIR和UV-Vis)和联用色谱(UHPLC-qTOF-MS)分析苦瓜叶提取物的体外生物活性。
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-09-28 eCollection Date: 2021-01-01 DOI: 10.1155/2021/2854217
X E Mabasa, L M Mathomu, N E Madala, E M Musie, M T Sigidi

Momordica balsamina (M. balsamina) is a medicinal herb comprising health-promoting secondary metabolites. This study was aimed to profile bioactive compounds in the methanolic extract of M. balsamina leaves using molecular spectroscopic (UV-Vis and FTIR) and hyphenated chromatographic (UHPLC-qTOF-MS) techniques and evaluate the biological (in vitro anti-inflammatory and cytotoxicity) activities of the extract. The preliminary phytochemical screening tests revealed the presence of cardiac glycosides, flavonoids, saponins, tannins, and terpenoids. The UV-Vis profile revealed various absorption bands ranging from 200 to 750 nm, indicating the presence of flavonoids, phenolic compounds, tannins, terpenoids, carotenoids, chlorophyll, and alkaloids. FTIR spectra confirmed the presence of alkaloids, flavonoids, terpenes, anthraquinones, and phenolic compounds. A high-resolution and accurate mass spectrometer (LC-QTOF-MS model LC-MS-9030 instrument) was used, and the results confirmed the presence of flavonoid aglycones, such as quercetin, isorhamnetin, and kaempferol, as well as pseudolaroside A and dicaffeoylquinic and feruloyl isocitric acids. To the best of our knowledge, this is the first report of pseudolaroside A dimer and feruloyl isocitric acid in M. balsamina leaves. In vitro cytotoxicity assay showed that the extract was nontoxic against human colorectal adenocarcinoma (HT29 and Caco2), Vero, and RAW 264.7 cells. However, the extract showed anti-inflammatory activity on RAW 264.7 cells. The study confirmed that M. balsamina leaves contain nontoxic secondary metabolites that may play a pivotal role in human health as anti-inflammatory agents.

苦瓜(M. balsamina)是一种含有促进健康的次级代谢物的草药。采用分子光谱(UV-Vis和FTIR)和联用色谱(UHPLC-qTOF-MS)技术分析香参叶甲醇提取物的活性成分,并评价其体外抗炎和细胞毒性活性。初步的植物化学筛选试验显示心脏苷、黄酮类、皂苷、单宁和萜类化合物的存在。紫外可见光谱显示200 ~ 750nm的不同吸收波段,表明黄酮类化合物、酚类化合物、单宁、萜类化合物、类胡萝卜素、叶绿素和生物碱的存在。FTIR光谱证实其含有生物碱、黄酮类、萜烯类、蒽醌类和酚类化合物。采用高分辨率、高精度质谱仪(LC-QTOF-MS模型LC-MS-9030)分析,结果证实了槲皮素、异鼠李素、山奈酚等类黄酮苷元、假花叶苷A、二咖啡酰奎尼酸和阿魏酰异柠檬酸的存在。据我们所知,这是首次报道假花苷A二聚体和阿魏酰异柠檬酸在香草叶中。体外细胞毒性实验表明,提取物对人结直肠癌(HT29和Caco2)、Vero和RAW 264.7细胞无毒性。然而,提取物对RAW 264.7细胞具有抗炎活性。该研究证实,凤仙花叶含有无毒的次生代谢物,可能作为抗炎剂在人体健康中发挥关键作用。
{"title":"Molecular Spectroscopic (FTIR and UV-Vis) and Hyphenated Chromatographic (UHPLC-qTOF-MS) Analysis and <i>In Vitro</i> Bioactivities of the <i>Momordica balsamina</i> Leaf Extract.","authors":"X E Mabasa,&nbsp;L M Mathomu,&nbsp;N E Madala,&nbsp;E M Musie,&nbsp;M T Sigidi","doi":"10.1155/2021/2854217","DOIUrl":"https://doi.org/10.1155/2021/2854217","url":null,"abstract":"<p><p><i>Momordica balsamina</i> (<i>M. balsamina</i>) is a medicinal herb comprising health-promoting secondary metabolites. This study was aimed to profile bioactive compounds in the methanolic extract of <i>M. balsamina</i> leaves using molecular spectroscopic (UV-Vis and FTIR) and hyphenated chromatographic (UHPLC-qTOF-MS) techniques and evaluate the biological (<i>in vitro</i> anti-inflammatory and cytotoxicity) activities of the extract. The preliminary phytochemical screening tests revealed the presence of cardiac glycosides, flavonoids, saponins, tannins, and terpenoids. The UV-Vis profile revealed various absorption bands ranging from 200 to 750 nm, indicating the presence of flavonoids, phenolic compounds, tannins, terpenoids, carotenoids, chlorophyll, and alkaloids. FTIR spectra confirmed the presence of alkaloids, flavonoids, terpenes, anthraquinones, and phenolic compounds. A high-resolution and accurate mass spectrometer (LC-QTOF-MS model LC-MS-9030 instrument) was used, and the results confirmed the presence of flavonoid aglycones, such as quercetin, isorhamnetin, and kaempferol, as well as pseudolaroside A and dicaffeoylquinic and feruloyl isocitric acids. To the best of our knowledge, this is the first report of pseudolaroside A dimer and feruloyl isocitric acid in <i>M. balsamina</i> leaves. <i>In vitro</i> cytotoxicity assay showed that the extract was nontoxic against human colorectal adenocarcinoma (HT29 and Caco2), Vero, and RAW 264.7 cells. However, the extract showed anti-inflammatory activity on RAW 264.7 cells. The study confirmed that <i>M. balsamina</i> leaves contain nontoxic secondary metabolites that may play a pivotal role in human health as anti-inflammatory agents.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"2854217"},"PeriodicalIF":3.0,"publicationDate":"2021-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39495962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Baicalein Mediates Mitochondrial Autophagy via miR-30b and the NIX/BNIP3 Signaling Pathway in Parkinson's Disease. 黄芩素通过miR-30b和NIX/BNIP3信号通路介导帕金森病线粒体自噬
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-08-18 eCollection Date: 2021-01-01 DOI: 10.1155/2021/2319412
Min Chen, Li Peng, Ping Gong, Xiaoli Zheng, Tao Sun, Xiaoqiao Zhang, Jiangtao Huo

Parkinson's disease (PD) is regarded as a severe neurodegenerative disorder. Baicalein is involved in the treatment of PD. This study explored the mechanism of baicalein in PD. The PD rat model was established using 6-hydroxydopamine. The neurologic score, dopamine (DA) content, apoptotic cells, and neuronal damage were evaluated after rats were treated with baicalein. Autophagy in PD rats was inhibited using 3-methyladenine (3-MA). The mitochondrial membrane potential (MMP) and autophagy-related proteins (LC3, P62) were detected. Next, agomiR-30b was transfected into PD rats. The targeting relation between miR-30b and NIX was predicted and verified. Then, sh-NIX was transfected into PD rats, and the effects of miR-30b and NIX on MMP, LC3, and P62 were assessed. When miR-30b was overexpressed using agomiR-30b, the NIX and BNIP3 levels were detected. Baicalein increased the neurological score and restored DA content, neurons, MMP, and mitochondrial autophagy protein levels. Baicalein inhibited miR-30b expression and miR-30b targeted NIX. miR-30b upregulation or NIX silencing reversed the effect of baicalein on MMP and mitochondrial autophagy. Baicalein upregulated NIX and BNIP3 expressions, while miR-30b overexpression inhibited NIX and BNIP3 expressions. In summary, baicalein mediated mitochondrial autophagy and restored neuronal activity by downregulating miR-30b and activating the NIX/BNIP3 pathway, thus protecting against PD.

帕金森病(PD)是一种严重的神经退行性疾病。黄芩苷参与PD的治疗。本研究探讨黄芩素在帕金森病中的作用机制。采用6-羟多巴胺建立PD大鼠模型。观察黄芩素给药后大鼠神经功能评分、多巴胺(DA)含量、细胞凋亡及神经元损伤情况。3-甲基腺嘌呤(3-MA)可抑制PD大鼠的自噬。检测线粒体膜电位(MMP)和自噬相关蛋白(LC3、P62)。然后,将agomiR-30b转染PD大鼠。预测并验证miR-30b与NIX的靶向关系。然后将sh-NIX转染PD大鼠,评估miR-30b和NIX对MMP、LC3和P62的影响。当使用agomiR-30b过表达miR-30b时,检测NIX和BNIP3水平。黄芩苷增加神经系统评分,恢复DA含量、神经元、MMP和线粒体自噬蛋白水平。黄芩素抑制miR-30b表达和miR-30b靶向NIX。miR-30b上调或NIX沉默可逆转黄芩素对MMP和线粒体自噬的影响。黄芩素上调NIX和BNIP3的表达,而miR-30b过表达抑制NIX和BNIP3的表达。综上所述,黄芩素通过下调miR-30b和激活NIX/BNIP3通路介导线粒体自噬,恢复神经元活性,从而保护PD。
{"title":"Baicalein Mediates Mitochondrial Autophagy via miR-30b and the NIX/BNIP3 Signaling Pathway in Parkinson's Disease.","authors":"Min Chen,&nbsp;Li Peng,&nbsp;Ping Gong,&nbsp;Xiaoli Zheng,&nbsp;Tao Sun,&nbsp;Xiaoqiao Zhang,&nbsp;Jiangtao Huo","doi":"10.1155/2021/2319412","DOIUrl":"https://doi.org/10.1155/2021/2319412","url":null,"abstract":"<p><p>Parkinson's disease (PD) is regarded as a severe neurodegenerative disorder. Baicalein is involved in the treatment of PD. This study explored the mechanism of baicalein in PD. The PD rat model was established using 6-hydroxydopamine. The neurologic score, dopamine (DA) content, apoptotic cells, and neuronal damage were evaluated after rats were treated with baicalein. Autophagy in PD rats was inhibited using 3-methyladenine (3-MA). The mitochondrial membrane potential (MMP) and autophagy-related proteins (LC3, P62) were detected. Next, agomiR-30b was transfected into PD rats. The targeting relation between miR-30b and NIX was predicted and verified. Then, sh-NIX was transfected into PD rats, and the effects of miR-30b and NIX on MMP, LC3, and P62 were assessed. When miR-30b was overexpressed using agomiR-30b, the NIX and BNIP3 levels were detected. Baicalein increased the neurological score and restored DA content, neurons, MMP, and mitochondrial autophagy protein levels. Baicalein inhibited miR-30b expression and miR-30b targeted NIX. miR-30b upregulation or NIX silencing reversed the effect of baicalein on MMP and mitochondrial autophagy. Baicalein upregulated NIX and BNIP3 expressions, while miR-30b overexpression inhibited NIX and BNIP3 expressions. In summary, baicalein mediated mitochondrial autophagy and restored neuronal activity by downregulating miR-30b and activating the NIX/BNIP3 pathway, thus protecting against PD.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"2319412"},"PeriodicalIF":3.0,"publicationDate":"2021-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39380584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Identification of Prognostic Genes in Neuroblastoma in Children by Weighted Gene Coexpression Network Analysis. 加权基因共表达网络分析鉴定儿童神经母细胞瘤预后基因。
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-07-27 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9987990
Jun Yang, Ying Zhang, Jiaying Zhou, Shaohua Wang

Background: Neuroblastoma is a malignant neuroendocrine tumor from the sympathetic nervous system, the most common extracranial tumor in children. Identifying potential prognostic markers of neuroblastoma can provide clues for early diagnosis, recurrence, and treatment.

Methods: RNA sequence data and clinical features of 147 neuroblastomas were obtained from the TARGET (Therapeutically Applicable Research to Generate Effective Treatments project) database. Application weighted gene coexpression network analysis (WGCNA) was used to construct a free-scale gene coexpression network, to study the interrelationship between its potential modules and clinical features, and to identify hub genes in the module. We performed Lasso regression and Cox regression analyses to identify the three most important genes and develop a new prognostic model. Data from the GSE85047 cohort verified the predictive accuracy of the prognostic model.

Results: 14 coexpression modules were constructed using WGCNA. Brown coexpression modules were found to be significantly associated with disease survival status. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analyses using the Cox proportional hazards regression model. Finally, we constructed a three-gene prognostic model: risk score = (0.003812659CKB) + (-0.152376975expDST) + (0.032032815expDUT). The prognosis of samples in the high-risk group was significantly poorer than that of samples in the low-risk group (P=1.225e - 06). The risk model was also regarded as an independent predictor of prognosis (HR = 1.632; 95% CI = 1.391-1.934; P < 0.001).

Conclusion: Our study constructed a neuroblastoma coexpressing gene module and identified a prognostic potential risk model for prognosis in neuroblastoma.

背景:神经母细胞瘤是一种来自交感神经系统的恶性神经内分泌肿瘤,是儿童最常见的颅外肿瘤。识别神经母细胞瘤的潜在预后标记可以为早期诊断、复发和治疗提供线索。方法:从TARGET (Therapeutically applied Research to Generate Effective therapies project)数据库中获取147例神经母细胞瘤的RNA序列数据和临床特征。应用加权基因共表达网络分析(WGCNA)构建自由尺度基因共表达网络,研究其潜在模块与临床特征之间的相互关系,并识别模块中的枢纽基因。我们通过Lasso回归和Cox回归分析来确定三个最重要的基因,并建立了一个新的预后模型。来自GSE85047队列的数据验证了预后模型的预测准确性。结果:WGCNA共构建了14个共表达模块。发现棕色共表达模块与疾病生存状态显著相关。采用Cox比例风险回归模型对基因进行单因素Cox回归和Lasso回归分析。最后,我们构建了一个三基因预后模型:风险评分=(0.003812659∗CKB) +(-0.152376975∗expDST) +(0.032032815∗expDUT)。高危组患者预后明显差于低危组患者(P=1.225e - 06)。风险模型也被认为是预后的独立预测因子(HR = 1.632;95% ci = 1.391-1.934;P < 0.001)。结论:本研究构建了神经母细胞瘤共表达基因模块,确定了神经母细胞瘤预后的预后潜在风险模型。
{"title":"Identification of Prognostic Genes in Neuroblastoma in Children by Weighted Gene Coexpression Network Analysis.","authors":"Jun Yang,&nbsp;Ying Zhang,&nbsp;Jiaying Zhou,&nbsp;Shaohua Wang","doi":"10.1155/2021/9987990","DOIUrl":"https://doi.org/10.1155/2021/9987990","url":null,"abstract":"<p><strong>Background: </strong>Neuroblastoma is a malignant neuroendocrine tumor from the sympathetic nervous system, the most common extracranial tumor in children. Identifying potential prognostic markers of neuroblastoma can provide clues for early diagnosis, recurrence, and treatment.</p><p><strong>Methods: </strong>RNA sequence data and clinical features of 147 neuroblastomas were obtained from the TARGET (Therapeutically Applicable Research to Generate Effective Treatments project) database. Application weighted gene coexpression network analysis (WGCNA) was used to construct a free-scale gene coexpression network, to study the interrelationship between its potential modules and clinical features, and to identify hub genes in the module. We performed Lasso regression and Cox regression analyses to identify the three most important genes and develop a new prognostic model. Data from the GSE85047 cohort verified the predictive accuracy of the prognostic model.</p><p><strong>Results: </strong>14 coexpression modules were constructed using WGCNA. Brown coexpression modules were found to be significantly associated with disease survival status. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analyses using the Cox proportional hazards regression model. Finally, we constructed a three-gene prognostic model: risk score = (0.003812659<i>∗</i>CKB) + (-0.152376975<i>∗</i>expDST) + (0.032032815<i>∗</i>expDUT). The prognosis of samples in the high-risk group was significantly poorer than that of samples in the low-risk group (<i>P</i>=1.225<i>e</i> - 06). The risk model was also regarded as an independent predictor of prognosis (HR = 1.632; 95% CI = 1.391-1.934; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Our study constructed a neuroblastoma coexpressing gene module and identified a prognostic potential risk model for prognosis in neuroblastoma.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"9987990"},"PeriodicalIF":3.0,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39280036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated Rats. 益生菌对丙烯酰胺处理大鼠促炎细胞因子水平的调节作用。
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-07-20 eCollection Date: 2021-01-01 DOI: 10.1155/2021/2268770
Seyed Mohammad Seifati, Erfan Zaker, Farzaneh Fesahat, Fateme Zare, Seyedhossein Hekmatimoghaddam

The aims of this study are to investigate the effect of acrylamide on the level of proinflammatory cytokines in the blood of acrylamide-treated rats and to find the modulatory impact of probiotics on those cytokines. Thirty-two rats were divided into four groups: rats which received 20 mg acrylamide, acrylamide with 20 mg probiotics, acrylamide with 200 mg probiotics, and standard water and food (groups 1-4, respectively). The serum levels of cytokines were measured on days 0, 15, and 30. Group 1 showed an increased serum level of IL-1β, IL-6, and TNF-α after 15 days, and they decreased in day 30. Serum IL-6 level was significantly decreased on days 15 and 30 in rats in group 2 compared to the controls. TNF-α and IL-1β levels were not statistically different after treated with probiotics. The exposure of rats to acrylamide led to increased systemic inflammation as evidenced by higher levels of proinflammatory cytokines, and probiotics can modulate this inflammation.

本研究旨在探讨丙烯酰胺对丙烯酰胺处理大鼠血液中促炎细胞因子水平的影响,并探讨益生菌对这些细胞因子的调节作用。将32只大鼠分为4组:分别给予丙烯酰胺20 mg、丙烯酰胺加益生菌20 mg、丙烯酰胺加益生菌200 mg、标准水和食物(1-4组)。于第0、15、30天测定血清细胞因子水平。第1组小鼠血清IL-1β、IL-6、TNF-α水平在第15天升高,第30天降低。与对照组相比,2组大鼠血清IL-6水平在第15天和第30天显著降低。经益生菌处理后TNF-α和IL-1β水平无统计学差异。大鼠暴露于丙烯酰胺导致全身炎症增加,促炎细胞因子水平升高证明了这一点,而益生菌可以调节这种炎症。
{"title":"Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated Rats.","authors":"Seyed Mohammad Seifati,&nbsp;Erfan Zaker,&nbsp;Farzaneh Fesahat,&nbsp;Fateme Zare,&nbsp;Seyedhossein Hekmatimoghaddam","doi":"10.1155/2021/2268770","DOIUrl":"https://doi.org/10.1155/2021/2268770","url":null,"abstract":"<p><p>The aims of this study are to investigate the effect of acrylamide on the level of proinflammatory cytokines in the blood of acrylamide-treated rats and to find the modulatory impact of probiotics on those cytokines. Thirty-two rats were divided into four groups: rats which received 20 mg acrylamide, acrylamide with 20 mg probiotics, acrylamide with 200 mg probiotics, and standard water and food (groups 1-4, respectively). The serum levels of cytokines were measured on days 0, 15, and 30. Group 1 showed an increased serum level of IL-1<i>β</i>, IL-6, and TNF-<i>α</i> after 15 days, and they decreased in day 30. Serum IL-6 level was significantly decreased on days 15 and 30 in rats in group 2 compared to the controls. TNF-<i>α</i> and IL-1<i>β</i> levels were not statistically different after treated with probiotics. The exposure of rats to acrylamide led to increased systemic inflammation as evidenced by higher levels of proinflammatory cytokines, and probiotics can modulate this inflammation.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"2268770"},"PeriodicalIF":3.0,"publicationDate":"2021-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39273452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis. 2019冠状病毒病相关儿童多系统炎症综合征:系统综述和荟萃分析
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-07-15 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5596727
Ji-Gan Wang, Zhi-Juan Zhong, Meng Li, Jun Fu, Yu-Heng Su, You-Min Ping, Zi-Ji Xu, Hao Li, Yan-Hao Chen, Yu-Li Huang

Background: This study aimed to describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.

Methods: We employed a literature search of databases such as PubMed, Web of Science, EMBASE, and Johns Hopkins University for articles on COVID-19-related multisystem inflammatory syndrome in children published between April 1, 2020, and January 15, 2021. High-quality articles were selected for analysis on the basis of their quality standard scores. Using R3.6.3 software, meta-analyses of random- or fixed-effects models were used to determine the prevalence of comorbidities. Subgroup analysis was also performed to determine heterogeneity.

Results: A total of 57 articles (2,290 pediatric patients) were included in the study. Clinical Manifestations. :ncidences of fever, gastrointestinal symptoms, respiratory symptoms, and musculoskeletal symptoms (myalgias or arthralgias) were 99.91% (95% CI: 99.67-100%), 82.72% (95% CI: 78.19-86.81%), 53.02% (45.28-60.68%), and 14.16% (95% CI: 8.4-21.12%), respectively. The incidences of rash, conjunctival injection, lymphadenopathy, dry cracked lips, neurologic symptoms (headache, altered mental status, or confusion), swollen hands and feet, typical Kawasaki disease, and atypical Kawasaki disease were 59.34% (95% CI: 54.73-63.87%), 55.23% (95% CI: 50.22-60.19%), 27.07% (95% CI: 19.87-34.93%), 46.37% (95% CI: 39.97-52.83%), 28.87% (95% CI: 22.76-35.40%), 28.75% (95% CI: 21.46-36.64%), 17.32% (95% CI: 15.44-19.29%), and 36.19% (95% CI: 21.90-51.86%), respectively. The incidences of coronary artery dilation, aneurysm, pericardial effusion, myocarditis, myocardial dysfunction, high troponin, and N-terminal pro-B-type natriuretic peptide were 17.83%, 6.85%, 20.97%, 35.97%, 56.32%, 76.34%, and 86.65%, respectively. The incidences of reduced lymphocytes, thrombocytopenia, hypoalbuminemia, elevated C-reactive protein, ferritin, LDH, interleukin-6, PCT, and FIB were 61.51%, 26.42%, 77.92%, 98.5%, 86.79%, 80.59%, 89.30%, 85.10%, and 87.01%, respectively. PICU Hospitalization Rate and Mortality. The incidences of PICU hospitalization or with shock were 72.79% and 55.68%, respectively. The mortality rate was 1.00%. Conclusion and Relevance. PICU hospitalization and shock rates of multisystem inflammatory syndrome in children associated with COVID-19 were high, and its cumulative multiorgans and inflammatory indicators are increased, but if treated in time, the mortality rate was low.

背景:本研究旨在描述2019冠状病毒病相关儿童多系统炎症综合征的临床症状、实验室检查、治疗和结局,为临床实践提供参考。方法:检索PubMed、Web of Science、EMBASE和Johns Hopkins University等数据库,检索2020年4月1日至2021年1月15日期间发表的与covid -19相关的儿童多系统炎症综合征的文章。根据质量标准得分选择高质量的文章进行分析。采用R3.6.3软件对随机或固定效应模型进行meta分析,确定合并症的发生率。还进行了亚组分析以确定异质性。结果:共有57篇文章(2290名儿科患者)被纳入研究。临床表现。发热、胃肠道症状、呼吸道症状和肌肉骨骼症状(肌痛或关节痛)的发生率分别为99.91% (95% CI: 99.67-100%)、82.72% (95% CI: 78.19-86.81%)、53.02%(45.28-60.68%)和14.16% (95% CI: 8.4-21.12%)。皮疹的发生率,结膜充血,淋巴结病,干燥的嘴唇干裂,神经症状(头痛、精神状态改变、或混淆),双手和双脚肿胀,典型川崎病,和非典型川崎病是59.34% (95% CI: 54.73—-63.87%),55.23% (95% CI: 50.22—-60.19%),27.07% (95% CI: 19.87—-34.93%),46.37% (95% CI: 39.97—-52.83%),28.87% (95% CI: 22.76—-35.40%),28.75% (95% CI: 21.46—-36.64%),17.32% (95% CI: 15.44—-19.29%)和36.19%(95%置信区间CI:分别为21.90 - -51.86%)。冠状动脉扩张、动脉瘤、心包积液、心肌炎、心肌功能障碍、高肌钙蛋白、n端前b型利钠肽的发生率分别为17.83%、6.85%、20.97%、35.97%、56.32%、76.34%、86.65%。淋巴细胞减少、血小板减少、低白蛋白血症、c反应蛋白、铁蛋白、LDH、白细胞介素-6、PCT和FIB升高的发生率分别为61.51%、26.42%、77.92%、98.5%、86.79%、80.59%、89.30%、85.10%和87.01%。PICU住院率和死亡率。PICU住院和合并休克的发生率分别为72.79%和55.68%。死亡率为1.00%。结论和相关性。COVID-19患儿多系统炎症综合征PICU住院率和休克率较高,其累积多器官及炎症指标升高,但如果及时治疗,死亡率较低。
{"title":"Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.","authors":"Ji-Gan Wang,&nbsp;Zhi-Juan Zhong,&nbsp;Meng Li,&nbsp;Jun Fu,&nbsp;Yu-Heng Su,&nbsp;You-Min Ping,&nbsp;Zi-Ji Xu,&nbsp;Hao Li,&nbsp;Yan-Hao Chen,&nbsp;Yu-Li Huang","doi":"10.1155/2021/5596727","DOIUrl":"https://doi.org/10.1155/2021/5596727","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.</p><p><strong>Methods: </strong>We employed a literature search of databases such as PubMed, Web of Science, EMBASE, and Johns Hopkins University for articles on COVID-19-related multisystem inflammatory syndrome in children published between April 1, 2020, and January 15, 2021. High-quality articles were selected for analysis on the basis of their quality standard scores. Using R3.6.3 software, meta-analyses of random- or fixed-effects models were used to determine the prevalence of comorbidities. Subgroup analysis was also performed to determine heterogeneity.</p><p><strong>Results: </strong>A total of 57 articles (2,290 pediatric patients) were included in the study. <i>Clinical Manifestations</i>. :ncidences of fever, gastrointestinal symptoms, respiratory symptoms, and musculoskeletal symptoms (myalgias or arthralgias) were 99.91% (95% CI: 99.67-100%), 82.72% (95% CI: 78.19-86.81%), 53.02% (45.28-60.68%), and 14.16% (95% CI: 8.4-21.12%), respectively. The incidences of rash, conjunctival injection, lymphadenopathy, dry cracked lips, neurologic symptoms (headache, altered mental status, or confusion), swollen hands and feet, typical Kawasaki disease, and atypical Kawasaki disease were 59.34% (95% CI: 54.73-63.87%), 55.23% (95% CI: 50.22-60.19%), 27.07% (95% CI: 19.87-34.93%), 46.37% (95% CI: 39.97-52.83%), 28.87% (95% CI: 22.76-35.40%), 28.75% (95% CI: 21.46-36.64%), 17.32% (95% CI: 15.44-19.29%), and 36.19% (95% CI: 21.90-51.86%), respectively. The incidences of coronary artery dilation, aneurysm, pericardial effusion, myocarditis, myocardial dysfunction, high troponin, and <i>N</i>-terminal pro-B-type natriuretic peptide were 17.83%, 6.85%, 20.97%, 35.97%, 56.32%, 76.34%, and 86.65%, respectively. The incidences of reduced lymphocytes, thrombocytopenia, hypoalbuminemia, elevated C-reactive protein, ferritin, LDH, interleukin-6, PCT, and FIB were 61.51%, 26.42%, 77.92%, 98.5%, 86.79%, 80.59%, 89.30%, 85.10%, and 87.01%, respectively. <i>PICU Hospitalization Rate and Mortality</i>. The incidences of PICU hospitalization or with shock were 72.79% and 55.68%, respectively. The mortality rate was 1.00%. <i>Conclusion and Relevance</i>. PICU hospitalization and shock rates of multisystem inflammatory syndrome in children associated with COVID-19 were high, and its cumulative multiorgans and inflammatory indicators are increased, but if treated in time, the mortality rate was low.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"5596727"},"PeriodicalIF":3.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39273453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Simultaneous Determination of 78 Compounds of Rhodiola rosea Extract by Supercritical CO2-Extraction and HPLC-ESI-MS/MS Spectrometry. 超临界co2萃取- HPLC-ESI-MS/MS法同时测定红景天提取物中78种化合物
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-07-06 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9957490
Alexander M Zakharenko, Mayya P Razgonova, Konstantin S Pikula, Kirill S Golokhvast

The plant Rhodiola rosea L. of family Crassulaceae was extracted using the supercritical CO2-extraction method. Several experimental conditions were investigated in the pressure range of 200-500 bar, with the used volume of cosolvent ethanol in the amount of 1% in the liquid phase at a temperature in the range of 31-70°C. The most effective extraction conditions are pressure 350 bar and temperature 60°C. The extracts were analyzed by HPLC with MS/MS identification. 78 target analytes were isolated from Rhodiola rosea (Russia) using a series of column chromatography and mass spectrometry experiments. The results of the analysis showed a spectrum of the main active ingredients Rh. rosea: salidroside, rhodiolosides (B and C), rhodiosin, luteolin, catechin, quercetin, quercitrin, herbacetin, sacranoside A, vimalin, and others. In addition to the reported metabolites, 29 metabolites were newly annotated in Rh. rosea. There were flavonols: dihydroquercetin, acacetin, mearnsetin, and taxifolin-O-pentoside; flavones: apigenin-O-hexoside derivative, tricetin trimethyl ether 7-O-hexosyl-hexoside, tricin 7-O-glucoronyl-O-hexoside, tricin O-pentoside, and tricin-O-dihexoside; flavanones: eriodictyol-7-O-glucoside; flavan-3-ols: gallocatechin, hydroxycinnamic acid caffeoylmalic acid, and di-O-caffeoylquinic acid; coumarins: esculetin; esculin: fraxin; and lignans: hinokinin, pinoresinol, L-ascorbic acid, glucaric acid, palmitic acid, and linolenic acid. The results of supercritical CO2-extraction from roots and rhizomes of Rh. rosea, in particular, indicate that the extract contained all biologically active components of the plant, as well as inert mixtures of extracted compositions.

采用超临界co2萃取法提取了天竺葵科植物红景天。在压力为200- 500bar,液相共溶剂乙醇用量为1%,温度为31-70℃的条件下,研究了几种实验条件。最有效的提取条件是压力350巴,温度60℃。采用高效液相色谱-质谱联用技术对提取物进行分析。采用柱层析和质谱分析方法,从俄罗斯红景天中分离得到78种目标分析物。分析结果显示了主要有效成分Rh的谱图。玫瑰红:红景天苷、红景天苷(B和C)、红景天素、木犀草素、儿茶素、槲皮素、槲皮素、草菌素、沙果苷A、维马林等。除了已报道的代谢物外,在Rh中还新注释了29种代谢物。rosea。黄酮醇有:二氢槲皮素、金合欢素、马齿苋素和紫杉醇- o -戊苷;黄酮类化合物:芹菜素- o -己糖苷衍生物、三甲素三甲基醚7- o -己糖苷、三甲素- 7- o -己糖苷、三甲素- o -葡萄糖醛基- o -己糖苷、三甲素- o -戊糖苷和三甲素- o -二己糖苷;黄烷酮类:eriodictyol-7-O-glucoside;黄烷-3-醇:没食子儿茶素、羟基肉桂酸、咖啡酰苹果酸和二o -咖啡酰奎宁酸;香豆素类:七叶亭;七叶灵:fraxin;木脂素:牛蒡子素、松脂醇、l -抗坏血酸、葡萄糖酸、棕榈酸和亚麻酸。超临界co2萃取Rh根和根茎的结果。特别是玫瑰红,表明提取物含有该植物的所有生物活性成分,以及提取成分的惰性混合物。
{"title":"Simultaneous Determination of 78 Compounds of <i>Rhodiola rosea</i> Extract by Supercritical CO<sub>2</sub>-Extraction and HPLC-ESI-MS/MS Spectrometry.","authors":"Alexander M Zakharenko,&nbsp;Mayya P Razgonova,&nbsp;Konstantin S Pikula,&nbsp;Kirill S Golokhvast","doi":"10.1155/2021/9957490","DOIUrl":"https://doi.org/10.1155/2021/9957490","url":null,"abstract":"<p><p>The plant <i>Rhodiola rosea</i> L. of family <i>Crassulaceae</i> was extracted using the supercritical CO<sub>2</sub>-extraction method. Several experimental conditions were investigated in the pressure range of 200-500 bar, with the used volume of cosolvent ethanol in the amount of 1% in the liquid phase at a temperature in the range of 31-70°C. The most effective extraction conditions are pressure 350 bar and temperature 60°C. The extracts were analyzed by HPLC with MS/MS identification. 78 target analytes were isolated from <i>Rhodiola rosea</i> (Russia) using a series of column chromatography and mass spectrometry experiments. The results of the analysis showed a spectrum of the main active ingredients <i>Rh. rosea</i>: salidroside, rhodiolosides (B and C), rhodiosin, luteolin, catechin, quercetin, quercitrin, herbacetin, sacranoside A, vimalin, and others. In addition to the reported metabolites, 29 metabolites were newly annotated in <i>Rh. rosea.</i> There were flavonols: dihydroquercetin, acacetin, mearnsetin, and taxifolin-O-pentoside; flavones: apigenin-O-hexoside derivative, tricetin trimethyl ether 7-O-hexosyl-hexoside, tricin 7-O-glucoronyl-O-hexoside, tricin O-pentoside, and tricin-O-dihexoside; flavanones: eriodictyol-7-O-glucoside; flavan-3-ols: gallocatechin, hydroxycinnamic acid caffeoylmalic acid, and di-O-caffeoylquinic acid; coumarins: esculetin; esculin: fraxin; and lignans: hinokinin, pinoresinol, L-ascorbic acid, glucaric acid, palmitic acid, and linolenic acid. The results of supercritical CO<sub>2</sub>-extraction from roots and rhizomes of <i>Rh. rosea</i>, in particular, indicate that the extract contained all biologically active components of the plant, as well as inert mixtures of extracted compositions.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"9957490"},"PeriodicalIF":3.0,"publicationDate":"2021-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39220532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Recent Advances in Enzymes for the Bioremediation of Pollutants. 污染物生物修复酶的研究进展。
IF 3 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-06-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5599204
Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Seyed Mohammad Iman Moezzi, Navid Ravan, Ahmad Gholami, Chin Wei Lai, Wei-Hung Chiang, Navid Omidifar, Khadije Yousefi, Gity Behbudi

Nowadays, pollution of the environment is a huge problem for humans and other organisms' health. Conventional methods of pollutant removal like membrane filtration or ion exchange are not efficient enough to lower the number of pollutants to standard levels. Biological methods, because of their higher efficiency and biocompatibility, are preferred for the remediation of pollutants. These cost-effective and environment-friendly methods of reducing pollutants are called bioremediation. In bioremediation methods, enzymes play the most crucial role. Enzymes can remedy different types of organic and inorganic pollutants, including PAHs, azo dyes, polymers, organocyanides, lead, chromium, and mercury. Different enzymes isolated from various species have been used for the bioremediation of pollutants. Discovering new enzymes and new subtypes with specific physicochemical characteristics would be a promising way to find more efficient and cost-effective tools for the remediation of pollutants.

如今,环境污染对人类和其他生物的健康是一个巨大的问题。传统的污染物去除方法,如膜过滤或离子交换,都不能有效地将污染物的数量降低到标准水平。生物方法因其效率高、生物相容性好而成为污染物修复的首选方法。这些既经济又环保的减少污染物的方法被称为生物修复。在生物修复方法中,酶起着最关键的作用。酶可以修复不同类型的有机和无机污染物,包括多环芳烃、偶氮染料、聚合物、有机氰化物、铅、铬和汞。从不同物种中分离的不同酶已被用于污染物的生物修复。发现具有特定物理化学特征的新酶和新亚型将是寻找更有效和更具成本效益的污染物修复工具的有希望的途径。
{"title":"Recent Advances in Enzymes for the Bioremediation of Pollutants.","authors":"Seyyed Mojtaba Mousavi,&nbsp;Seyyed Alireza Hashemi,&nbsp;Seyed Mohammad Iman Moezzi,&nbsp;Navid Ravan,&nbsp;Ahmad Gholami,&nbsp;Chin Wei Lai,&nbsp;Wei-Hung Chiang,&nbsp;Navid Omidifar,&nbsp;Khadije Yousefi,&nbsp;Gity Behbudi","doi":"10.1155/2021/5599204","DOIUrl":"https://doi.org/10.1155/2021/5599204","url":null,"abstract":"<p><p>Nowadays, pollution of the environment is a huge problem for humans and other organisms' health. Conventional methods of pollutant removal like membrane filtration or ion exchange are not efficient enough to lower the number of pollutants to standard levels. Biological methods, because of their higher efficiency and biocompatibility, are preferred for the remediation of pollutants. These cost-effective and environment-friendly methods of reducing pollutants are called bioremediation. In bioremediation methods, enzymes play the most crucial role. Enzymes can remedy different types of organic and inorganic pollutants, including PAHs, azo dyes, polymers, organocyanides, lead, chromium, and mercury. Different enzymes isolated from various species have been used for the bioremediation of pollutants. Discovering new enzymes and new subtypes with specific physicochemical characteristics would be a promising way to find more efficient and cost-effective tools for the remediation of pollutants.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"5599204"},"PeriodicalIF":3.0,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39319718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Antimalarial, Antioxidant, and Toxicological Evaluation of Extracts of Celtis africana, Grosseria vignei, Physalis micrantha, and Stachytarpheta angustifolia. 非洲草、粗毛菌、微花Physalis micrantha和stachytarphta angustifolia提取物的抗疟、抗氧化和毒理学评价。
IF 3.4 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2021-06-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9971857
Michael Konney Laryea, Lawrence Sheringham Borquaye

In many parts of the world, malaria undoubtedly poses a serious threat to health care systems. Malaria treatment has increasingly become complicated, primarily due to the emergence of widespread resistance of the malaria parasites to cheap and affordable malaria therapeutics. The use of herbal remedies to treat various ailments, including malaria and malaria-like ailments in Ghana is common. We herein report on the antiplasmodial and antioxidant activities as well as toxicological evaluation of four medicinal plants (Celtis africana, Grosseria vignei, Physalis micrantha, and Stachytarpheta angustifolia) commonly used to treat malaria in Ghana. Following Soxhlet extraction of plant samples in ethanol, extracts were screened against Plasmodium falciparum (3D7 strain) in an in vitro antiplasmodial assay. The phosphomolybdenum and DPPH (1, 1-diphenyl-2 picrylhydrazyl) assays were used to evaluate antioxidant activities while toxicity assessment was carried out in mice using the acute toxicity test and kidney and liver function tests. Extracts from Celtis africana and Physalis micrantha were very active towards the parasites with half-maximal inhibitory concentrations (IC50's) of 29.1 and 3.5 µg/mL, respectively. Extracts of Grosseria vignei and Stachytarpheta angustifolia were inactive, having IC50 values greater than 50 µg/mL. All extracts exhibited excellent total antioxidant capacities (>800 mg/g AAE) and good DPPH radical scavenging potential (IC50 range of 300-900 µg/mL). The median lethal dose (LD50) of all extracts in the toxicological evaluation was greater than 2000 mg/kg and there was no effect of extracts on the levels and activities of key biomarkers of liver and kidney function. The activities of these plants obtained in this study partly give credence to their folkloric use in herbal medicines and suggest that they could provide promising lead compounds for malaria drug discovery programs.

在世界许多地区,疟疾无疑对卫生保健系统构成严重威胁。疟疾治疗变得越来越复杂,主要是由于疟原虫对廉价和负担得起的疟疾治疗方法产生了广泛的耐药性。在加纳,使用草药治疗各种疾病很常见,包括疟疾和类似疟疾的疾病。我们在此报告了加纳常用于治疗疟疾的四种药用植物(非洲塞尔蒂斯(Celtis africana)、小黄藤(Grosseria vignei)、米柳(Physalis micrantha)和狭叶菊(Stachytarpheta angustifolia)的抗疟原虫和抗氧化活性以及毒理学评估。在乙醇中对植物样品进行索氏提取后,在体外抗疟原虫测定中对提取物进行抗恶性疟原虫(3D7株)的筛选。使用磷钼和DPPH(1,1-二苯基-2苦基肼基)测定法来评估抗氧化活性,同时使用急性毒性试验和肾、肝功能试验对小鼠进行毒性评估。非洲小蠊(Celtis africana)和薇甘菊(Physalis micrantha)的提取物对寄生虫非常活跃,半数最大抑制浓度(IC50)分别为29.1和3.5 µg/mL。Grosseria vignei和Stachytarpheta angustifolia的提取物没有活性,IC50值大于50 µg/mL。所有提取物都表现出优异的总抗氧化能力(>800 mg/gAAE)和良好的DPPH自由基清除潜力(IC50范围为300-900 µg/mL)。毒理学评估中所有提取物的半数致死剂量(LD50)均大于2000 mg/kg,并且提取物对肝和肾功能的关键生物标志物的水平和活性没有影响。这项研究中获得的这些植物的活性在一定程度上证明了它们在草药中的民间用途,并表明它们可以为疟疾药物发现项目提供有前景的先导化合物。
{"title":"Antimalarial, Antioxidant, and Toxicological Evaluation of Extracts of <i>Celtis africana</i>, <i>Grosseria vignei</i>, <i>Physalis micrantha</i>, and <i>Stachytarpheta angustifolia</i>.","authors":"Michael Konney Laryea, Lawrence Sheringham Borquaye","doi":"10.1155/2021/9971857","DOIUrl":"10.1155/2021/9971857","url":null,"abstract":"<p><p>In many parts of the world, malaria undoubtedly poses a serious threat to health care systems. Malaria treatment has increasingly become complicated, primarily due to the emergence of widespread resistance of the malaria parasites to cheap and affordable malaria therapeutics. The use of herbal remedies to treat various ailments, including malaria and malaria-like ailments in Ghana is common. We herein report on the antiplasmodial and antioxidant activities as well as toxicological evaluation of four medicinal plants (<i>Celtis africana</i>, <i>Grosseria vignei</i>, <i>Physalis micrantha</i>, and <i>Stachytarpheta angustifolia)</i> commonly used to treat malaria in Ghana. Following Soxhlet extraction of plant samples in ethanol, extracts were screened against <i>Plasmodium falciparum</i> (3D7 strain) in an <i>in vitro</i> antiplasmodial assay. The phosphomolybdenum and DPPH (1, 1-diphenyl-2 picrylhydrazyl) assays were used to evaluate antioxidant activities while toxicity assessment was carried out in mice using the acute toxicity test and kidney and liver function tests. Extracts from <i>Celtis africana</i> and <i>Physalis micrantha</i> were very active towards the parasites with half-maximal inhibitory concentrations (IC<sub>50</sub>'s) of 29.1 and 3.5 <i>µ</i>g/mL, respectively. Extracts of <i>Grosseria vignei</i> and <i>Stachytarpheta angustifolia</i> were inactive, having IC<sub>50</sub> values greater than 50 <i>µ</i>g/mL. All extracts exhibited excellent total antioxidant capacities (>800 mg/g AAE) and good DPPH radical scavenging potential (IC<sub>50</sub> range of 300-900 <i>µ</i>g/mL). The median lethal dose (LD<sub>50</sub>) of all extracts in the toxicological evaluation was greater than 2000 mg/kg and there was no effect of extracts on the levels and activities of key biomarkers of liver and kidney function. The activities of these plants obtained in this study partly give credence to their folkloric use in herbal medicines and suggest that they could provide promising lead compounds for malaria drug discovery programs.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"9971857"},"PeriodicalIF":3.4,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39181847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biochemistry Research International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1